Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX

Syndax Pharmaceuticals (SNDX) Stock Forecast & Price Target

423 Followers
See the Price Targets and Ratings of:

SNDX Analyst Ratings

Strong Buy
4Ratings
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Syndax
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SNDX Stock 12 Months Forecast

Average Price Target

$32.00
▲(30.03% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Syndax Pharmaceuticals in the last 3 months. The average price target is $32.00 with a high forecast of $34.00 and a low forecast of $29.00. The average price target represents a 30.03% change from the last price of $24.61.
Highest Price Target$34.00Average Price Target$32.00Lowest Price Target$29.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Goldman Sachs
$35.00
Buy
42.22%
Upside
Reiterated
Goldman Sachs Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $35
Robert W. Baird
$32.00
Buy
30.03%
Upside
Reiterated
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (NASDAQ: ENTA), Syndax Pharmaceuticals (NASDAQ: SNDX) and Apellis Pharmaceuticals (NASDAQ: APLS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SNDX Financial Forecast

SNDX Earnings Forecast
Next quarter’s earnings estimate for SNDX is -$0.66 with a range of -$0.71 to -$0.58. The previous quarter’s EPS was -$0.58. SNDX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.35% of the time in the same period. In the last calendar year SNDX has Outperformed its overall industry.
Next quarter’s earnings estimate for SNDX is -$0.66 with a range of -$0.71 to -$0.58. The previous quarter’s EPS was -$0.58. SNDX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.35% of the time in the same period. In the last calendar year SNDX has Outperformed its overall industry.
SNDX Sales Forecast
Next quarter’s sales forecast for SNDX is $1.60M with a range of $0.00 to $5.00M. The previous quarter’s sales results were $0.00. SNDX beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.99% of the time in the same period. In the last calendar year SNDX has Underperformed its overall industry.
Next quarter’s sales forecast for SNDX is $1.60M with a range of $0.00 to $5.00M. The previous quarter’s sales results were $0.00. SNDX beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.99% of the time in the same period. In the last calendar year SNDX has Underperformed its overall industry.
SNDX Analyst Recommendation Trends
In the current month, SNDX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SNDX average analyst price target in the past 3 months is $32.00
In the current month, SNDX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SNDX average analyst price target in the past 3 months is $32.00

SNDX Stock Forecast FAQ

What is SNDX’s average 12-month price target, according to analysts?
Based on analyst ratings, Syndax Pharmaceuticals’s 12-month average price target is $32.00.
    What is SNDX’s upside potential, based on the analysts’ average price target?
    Syndax Pharmaceuticals has 30.03% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SNDX a Buy, Sell or Hold?
          Syndax Pharmaceuticals has a conensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Syndax Pharmaceuticals’s price target?
            The average price target for Syndax Pharmaceuticals is $32.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $34.00 ,the lowest forecast is $29.00. The average price target represents 30.03% Increase from the current price of $24.61.
              What do analysts say about Syndax Pharmaceuticals?
              Syndax Pharmaceuticals’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis